MSD has expanded its presence in Ireland with an agreement to buy a vaccine manufacturing facility from Chinese biotech WuXi Biologics for around €500 million (around $520 million). The plant in ...

MSD's confidence in its anti-TL1A antibody tulisokibart in inflammatory diseases has been made apparent by a decision to start trials of the drug in three more indications. Already in phase 3 testing ...

This rewards program gets high marks from travelers for its relatively high potential point values and its flexible redemption options — including some top-notch transfer partners. Many or all of the ...

Students earn status by engaging in campus events, completing approved courses and participating in globally oriented experiences. Each status can be earned independently and repeated as students ...